Weight Loss Study (Phase 3 Clinical Trial)

Now Enrolling Adults Ages 18 or Older

Now Enrolling

About this research study

Obesity is associated with an increased risk of developing type 2 diabetes (T2D), hypertension, cardiovascular (CV) disease, obstructive sleep apnea, and many other medical conditions. Losing weight with lifestyle changes can be difficult to maintain long term, and weight-loss surgeries can present with major risks.

Velocity is now seeking participants for an investigational weight loss medication study in conjunction with lifestyle changes.

Eligible participants...

  • Must be age 18 or older
  • Must have a body mass index (BMI) of at least 30 kg/m2 or 27 kg/m2 with at least one of the following weight related comorbidities: hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease
  • Must NOT be diagnosed with T1D or T2D
  • Will receive compensation for study-related time
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

Enter your info

Study Locations

Los Angeles (Westlake), California • Velocity Clinical Research

2010 Wilshire Blvd, Suite 302, Los Angeles, CA 90057
Phone: (213) 483-1800

©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy